John Overdeck’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

John Overdeck’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,400	Closed	-$1.32M	–	4630
2021 Q4	$1.32M	Sell	7,400 -7,500	-50%	-$1.48M	﹤0.01%	2307
2021 Q3	$3.07M	Buy	14,900 +3,700	+33%	+$726K	0.01%	1594
2021 Q2	$2.13M	Buy	11,200 +1,800	+19%	+$295K	﹤0.01%	1819
2021 Q1	$1.22M	Buy	+9,400	New	+$1.13M	﹤0.01%	2123

Other funds holding SWAV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

John Overdeck's SWAV Position: Q1 2023 in Review

John Overdeck sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 11,128 shares — an estimated $2.29M sold.

John Overdeck first reported a position in SWAV in Q4 2020 and held it in 4 quarters. The position peaked at $4.01M in Q2 2021. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

John Overdeck reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
John Overdeck sold 11,128 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $2.29M.
John Overdeck first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
John Overdeck's Shockwave Medical, Inc. Common Stock position peaked at $4.01M in Q2 2021.
381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.